In their recent article in CHEST (May 2016) regarding the management of inferior vena cava (IVC) filters, Drs Arous and Messina recommend that filters be implanted on the basis of best available evidence, and be removed at 25 to 54 days postimplantation. By not distinguishing between high-risk and low-risk populations that receive IVC filters, the authors propagate an often inappropriate case report-driven obsession for filter removal. The patients at higher risk for pulmonary embolism (PE) are those who have filters placed for DVT, and the patients at lower risk are those who have filters placed because they had a transient elevated risk for the development of DVT. Differentiating these groups is important in any consideration on filter removal. In the cost/benefit analysis of whether to remove a filter, the costs, or complication risk of a filter over time, may be similar between those groups, but the benefit of a filter is different, as it is dependent on the risk of a patient developing a PE.